272 related articles for article (PubMed ID: 17675763)
21. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
[TBL] [Abstract][Full Text] [Related]
22. [Homozygous deletion of CDKN2/p16 gene in lung cancers].
Su C; Ye Y; Cao X; Shan X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):315-7. PubMed ID: 10514540
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.
Savic S; Franco N; Grilli B; Barascud Ade V; Herzog M; Bode B; Loosli H; Spieler P; Schönegg R; Zlobec I; Clark DP; Herman JG; Bubendorf L
Chest; 2010 Jul; 138(1):137-44. PubMed ID: 20139227
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study.
Ak G; Metintas S; Taskın AN; Uzel Sener M; Soyler Y; Yilmaz M; Turna A; Akin Kabalak P; Bilaceroglu S; Koksal D; Yilmaz Demirci N; Sogukpinar O; Boga S; Ercelik M; Karadeniz G; Polat G; Guldaval F; Aka Akturk U; Yilmaz S; Ogan N; Yilmaz S; Esendagli D; Caglayan B; Zeybek A; Durmus Kocak N; Mutlu P; Atinkaya Baytemir C; Sarbay I; Yilmaz U; Metintas M
Lung; 2022 Dec; 200(6):807-815. PubMed ID: 36173482
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions.
Hung MS; Lin CK; Leu SW; Wu MY; Tsai YH; Yang CT
Chang Gung Med J; 2006; 29(4):373-9. PubMed ID: 17051834
[TBL] [Abstract][Full Text] [Related]
26. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
27. Etiology of exudative pleural effusions in adults in North Lebanon.
Kalaajieh WK
Can Respir J; 2001; 8(2):93-7. PubMed ID: 11320400
[TBL] [Abstract][Full Text] [Related]
28. Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma.
Hamasaki M; Matsumoto S; Abe S; Hamatake D; Kamei T; Hiroshima K; Kawahara K; Sato A; Tsujimura T; Nakatani Y; Yoshida Y; Iwasaki A; Nabeshima K
Lung Cancer; 2016 Sep; 99():155-61. PubMed ID: 27565933
[TBL] [Abstract][Full Text] [Related]
29. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion.
Katayama H; Hiraki A; Aoe K; Fujiwara K; Matsuo K; Maeda T; Murakami T; Toyooka S; Sugi K; Ueoka H; Tanimoto M
Int J Cancer; 2007 May; 120(10):2191-5. PubMed ID: 17285579
[TBL] [Abstract][Full Text] [Related]
30. [Expression of survivin mRNA of sputum and pleural effusions in human lung cancer].
Dong DQ; Yang YH; Xue DY; Feng XJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):848-52. PubMed ID: 17213581
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of pleural fluid cytologic examination].
Zablockis R; Nargela R
Medicina (Kaunas); 2002; 38(12):1171-8. PubMed ID: 12552157
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity in pleural effusions: diagnostic significance.
Yang CT; Lee MH; Lan RS; Chen JK
J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
[TBL] [Abstract][Full Text] [Related]
33. Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
Lee CY; Hong JY; Lee MG; Suh IB
Yonsei Med J; 2017 Nov; 58(6):1144-1151. PubMed ID: 29047238
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
[TBL] [Abstract][Full Text] [Related]
35. Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations.
Nabeshima K; Matsumoto S; Hamasaki M; Hida T; Kamei T; Hiroshima K; Tsujimura T; Kawahara K
Diagn Cytopathol; 2016 Sep; 44(9):774-80. PubMed ID: 27219841
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
37. Procoagulant activity of purified protein derivative-stimulated pleural effusion mononuclear cells in tuberculous pleurisy.
Hoheisel G; Roth M; Chan CH; Tsakiris DA; Fehr B; Ruff PW; Perruchoud AP
Respiration; 1997; 64(2):152-8. PubMed ID: 9097351
[TBL] [Abstract][Full Text] [Related]
38. Value of DNA analysis in addition to cytological testing in the diagnosis of malignant pleural effusions.
Rodríguez de Castro F; Molero T; Acosta O; Julià-Serdà G; Caminero J; Cabrera P; Carrillo T
Thorax; 1994 Jul; 49(7):692-4. PubMed ID: 8066565
[TBL] [Abstract][Full Text] [Related]
39. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
Bao QL; Li J; Sun W; Jiang HG; Zhu LR; Wang Y
Jpn J Clin Oncol; 2014 Dec; 44(12):1198-205. PubMed ID: 25425729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
